The PIRAMIDE study, led by Giuditta Benincasa at the University of Campania Luigi Vanvitelli, aims to elucidate the interplay between DNA methylation and microRNA in T2D and its cardiovascular complications. Given the rising prevalence of T2D globally, understanding these molecular interactions could lead to novel prognostic biomarkers and therapeutic targets, enhancing the competitive landscape in diabetes management. The study's findings may provide insights that could be leveraged for developing epigenetic-based interventions or diagnostics, potentially positioning the sponsor favorably in the growing diabetes and cardiovascular disease markets.